Latest News

  • TECHNOLOGY

    18 Feb 2026

    How the Cloud Powers the Next mRNA Breakthrough

  • INSIGHTS

    16 Feb 2026

    Can Europe Win the mRNA Cancer Race?

  • REGULATORY

    12 Feb 2026

    FDA Refusal-to-File Resets mRNA Flu Strategy

  • INNOVATION

    11 Feb 2026

    Britain’s Bet On Better RNA Factories

Moderna and Recordati Bet on mRNA Beyond Vaccines

Syringe labeled Moderna mRNA-3927 with Recordati logo in background

PARTNERSHIPS

10 Feb 2026

Moderna and Recordati partner on an mRNA therapy for propionic acidemia, combining resources to accelerate development

Robotic hand interacting with molecular structures symbolizing AI-driven mRNA design.

INNOVATION

3 Dec 2025

AI Tools Edge Into mRNA Design

Early data from platforms like GEMORNA hint at faster mRNA design as drug makers weigh emerging AI approaches

Silhouette of a hand holding a syringe in front of BioNTech and Pfizer logos on a bright display background

PARTNERSHIPS

2 Dec 2025

A New mRNA Alliance Tests What Comes After COVID

Pfizer and BioNTech launch a collaborative mRNA R&D initiative that could shape future therapeutic development

Pipette dropping blue liquid into test tubes with DNA strand in background

INVESTMENT

1 Dec 2025

Can A Big Bet On mRNA Reset Biotech’s Pace?

Strand Therapeutics' $153M raise fuels momentum in targeted mRNA therapies and hints at a fast-advancing biotech shift

Syringe drawing dose from medical vial for mRNA vaccine research

PARTNERSHIPS

25 Nov 2025

The Push to Turn mRNA Into a Cancer Weapon

Pfizer and BioNTech deepen mRNA cancer vaccine development as competition grows and FDA signals supportive pathways

Automated production line filling COVID-19 vaccine vials in a sterile facility.

INSIGHTS

24 Nov 2025

Moderna’s Homegrown Bet Could Rewire Biotech’s Future

Moderna boosts US mRNA production, strengthening supply chains as firms like Pfizer explore on shore manufacturing

3D illustration of an mRNA lipid nanoparticle releasing RNA strands into surrounding molecules.

REGULATORY

20 Nov 2025

US MRNA Leaders Push for Regulatory Modernization as Innovation Surges

Moderna, Replicate, and others accelerate mRNA advances as the US faces rising pressure to update its regulatory approach

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.